<DOC>
	<DOCNO>NCT02829281</DOCNO>
	<brief_summary>Introduction : Osteoarthritis knee common disease . However treatment option patient . Botulinum toxin type A option chronic pain . If investigator prove effectiveness use intra-articular analgesia , Botulinum toxin type A useful treat patient . Objective : Compare effectiveness use intra-articular corticosteroid versus Botulinum toxin type A treatment patient knee osteoarthritis . Methods : A prospective control randomize double blind study three group ( n = 35 group ) patient symptomatic osteoarthritis knee receive intra-articular medication single moment undertaken . The three group : Botulinum toxin type A Group : patient receive 100 unit botulinum toxin ; hexacetonide triamcinolone Group : patient receive 40mg triamcinolone hexacetonide , saline group : patient receive 2ml normal saline . Patients assess evaluator `` blind `` 4 time 12 week follow-up clinical assessment instrument ( pain , quality life questionnaire short form 36 questionnaire ) , functional ( WOMAC questionnaire ) , ultrasound ( quantitative semi quantitative measure synovial hypertrophy semi quantitative Power Doppler ) .The follow statistical test use : Student 's test , Mann - Whitney , chi- square test ANOVA repeat measure . Will consider statistical significance difference 5 % .</brief_summary>
	<brief_title>Intra-articular Botox Type A Versus Corticosteroids Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>age 50 year diagnose knee osteoarthritis use clinic radiographic criterion pain 6 month analogic visual scale among 4 8 patient agree sign inform consent secondary osteoarthritis skin lesion use intraarticular corticosteroid last 3 month use oral corticosteroid last 30 day Kellgren Lawrence I IV inflammatory arthritis neuromuscular disease use aminoglycoside antibiotic metalic prosthesis knee peripheric neuropathy serious cardiovascular pulmonary disease serious disorder coagulation pregnancy breastfeed infection use wheelchair</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>knee osteoarthritis</keyword>
	<keyword>Intra-articular injection</keyword>
	<keyword>Botulinum Toxin Type A</keyword>
	<keyword>Corticosteroid</keyword>
</DOC>